ACOG Committee Opinion No. 338: Screening for Fragile X Syndrome
The DOI matches its Crossref record.
Abstract
Fragile X syndrome is the most common inherited form of mental retardation, affecting approximately 1 in 4,000 males and 1 in 8,000 females. DNA-based molecular analysis is the preferred method of diagnosis for fragile X syndrome and its premutations. Prenatal testing for fragile X syndrome should be offered to known carriers of the premutation or mutation. Testing for fragile X syndrome should be considered for any child with developmental delay of uncertain etiology, autism, or autistic behavior or for any individual with mental retardation of uncertain etiology. Women with ovarian failure or an elevated follicle-stimulating hormone level before 40 years of age without a known cause should be screened to determine whether they have the fragile X premutation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, however, preconception carrier testing has been recommended in the United States only for five of these: fragile × syndrome (OMIM #300624) in selected individuals; cystic fibrosis (OMIM #219700) in Caucasians; and TSD, Canavan disease (OMIM #271900), and familial dysautonomia (OMIM #223900) in individuals of Ashkenazi descent (9–13).”
From Carrier testing for severe childhood recessive diseases by next-generation sequencing (2011) · cites this paper as [10]
Citations
Cites
Still being checked.
Cited by
Nelson, L. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0808697 · Cited by 1,158
Carrier testing for severe childhood recessive diseases by next-generation sequencing
Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., Langley, R. J., Zhang, L., Lee, C. C., Schilkey, F. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001756 · Cited by 706
Genetics of primary ovarian insufficiency: new developments and opportunities
Qin, Y., Jiao, X., Simpson, J. L., & Chen, Z.-J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv036 · Cited by 554
Primary ovarian insufficiency: a more accurate term for premature ovarian failure
Welt, C. K. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03073.x · Cited by 538
The FMR1 premutation and reproduction
Wittenberger, M. D., Hagerman, R. J., Sherman, S. L., McConkie-Rosell, A., Welt, C. K., Rebar, R. W., Corrigan, E. C., Simpson, J. L., & Nelson, L. M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.09.004 · Cited by 412
Metadata
- Venue
- Obstetrics & Gynecology
- Published
- 2006-06
- Volume
- 107
- Issue
- 6
- Pages
- 1483
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W4252773034
- Cited by
- 79
- References
- 0
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 8 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 2 · 2012: 5
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- fragile X syndrome, fragile X premutation, screening, prenatal testing, developmental delay, autism spectrum disorder, intellectual disability, ovarian failure, follicle-stimulating hormone, DNA-based diagnosis, carrier screening
- MeSH terms
- Fragile X Syndrome, Humans, Mutation, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ACOG Committee Opinion No. 338: Screening for Fragile X Syndrome. https://app.cochat.ai/papers/10.1097/00006250-200606000-00059
- The paper
- ACOG Committee Opinion No. 338: Screening for Fragile X Syndrome. (2006). Obstetrics & Gynecology. https://doi.org/10.1097/00006250-200606000-00059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.